H93.1
Conditions
Interventions
Group 1: The intervention group receives manual therapy (MT) tailored to the medical assessment. This consists of 6 sessions of 30 minutes each, administered at a frequency of 1–3 treatments per week
Sponsors
Charité Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Presence of somatosensory tinnitus or a somatosensory component of tinnitus aurium - Clinical indication for manual therapy - General physical ability to participate in the study, including the ability to attend manual therapy appointments - Sufficient language comprehension and cognitive capacity to participate in the study - Willingness to participate and provision of written informed consent
Exclusion criteria
Exclusion criteria: - Other forms of tinnitus, such as central or pulse-synchronous tinnitus, as well as neurological accompanying symptoms such as diplopia or sudden hearing loss without prior ENT or neurological evaluation - Acute inflammatory processes, e.g. rheumatoid arthritis in the acute phase, infections involving the spine or joints - Recent fractures, spondylolisthesis, or post-traumatic instability - Tumors or metastases involving the spine or skull base - Severe osteoporosis, particularly involving the cervical spine, due to increased fracture risk - Neurological deficits of unclear origin, sudden-onset paresis, sensory disturbances, dizziness, or visual disturbances - Vascular disorders, e.g. stenosis of the vertebral artery, vertebral artery syndrome, aneurysms, or dissections - Stroke - Pronounced hypermobility, e.g. Ehlers-Danlos syndrome - Clinically relevant previous surgery of the head, neck, or ear - Psychiatric disorders in the acute phase - Expected study dropout, based on the assessment of the study physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Handicap Inventory (THI) Intervention group: T0 at the time of the 1st visit, T1 immediately after the last treatment (6th treatment, approximately 3 weeks later), T2 as follow-up approximately 6 weeks later. Control group: T0 at the time of the 1st visit, T1 after approximately 3 weeks, T2 immediately after the last treatment (6th treatment). | — |
Secondary
| Measure | Time frame |
|---|---|
| Tinnitus-related medical history VAS loudness of the tinnitus VAS perceived distress caused by the tinnitus VAS pain in the musculoskeletal system, shoulder-neck region Quality of life (EQ-5D) Psychological distress (HADS) Descriptive mapping of the primary movement directions modulating the tinnitus and corresponding muscle, fascial, and joint findings Intervention group: T0 at the time of the 1st visit, T1 immediately after the last treatment (6th treatment, approximately 3 weeks later), T2 as follow-up approximately 6 weeks later. Control group: T0 at the time of the 1st visit, T1 after approximately 3 weeks, T2 immediately after the last treatment (6th treatment). | — |
Countries
Germany
Contacts
Public ContactAnett Reißhauer
Arbeitsbereich Physikalische Medizin - Charité
Outcome results
None listed